Home
»çÀÌÆ®¸Ê
Contact Us
Eng
¼¾ÅͼҰ³
¿¬±¸¿µ¿ª
¿¬±¸È°µ¿
¿¬±¸½ÇÀû
ÀÚ·á½Ç
°Ô½ÃÆÇ
×
¼¾ÅͼҰ³
Àλ縻
¼³¸³¸ñÀû
¿¬Çõ
Á¶Á÷µµ
Âü¿©¿¬±¸Áø
½Ã¼³ ¹× Àåºñ
¿À½Ã´Â ±æ
¿¬±¸¿µ¿ª
ÀÓ»ó¾à¹°À¯Àüü¿¬±¸ºÎ
ºÐÀھ๰À¯Àüü¿¬±¸ºÎ
¾à¹°À¯Àüü¿¬±¸ Áö¿øºÎ
¿¬±¸È°µ¿
¿¬±¸»ç¾÷
¿¬±¸°³¹ß
¿¬±¸Çù·ÂÁö¿ø
Àη¾缺
¿¬±¸½ÇÀû
ÁßÁ¡¿¬±¸ÀÚ·á
³í¹®½ÇÀû
ÇÐȸ¹ßÇ¥
ƯÇã½ÇÀû
±âŸ½ÇÀû
ÀÚ·á½Ç
º¸µµÀÚ·á
»çÁøÀÚ·á
°ü·Ã»çÀÌÆ®
°Ô½ÃÆÇ
Çà»çÀÏÁ¤
°øÁö»çÇ×
¼¾ÅͼҽÄ
Çаè¼Ò½Ä
Contact Us
Eng
³í¹®½ÇÀû
¿¬±¸½ÇÀû
ÁßÁ¡¿¬±¸ÀÚ·á
³í¹®½ÇÀû
ÇÐȸ¹ßÇ¥
ƯÇã½ÇÀû
±âŸ½ÇÀû
Áö¿ø°úÁ¦º° :
¼±ÅÃÇϱâ
BMRC
BMRC, Japan Fund
BMRC, PRCDM
BMRC, ¼ö¼Ûü
cPMTb
FRONTIER
FRONTIER, PRCDM
NRL
NRL, PRCDM
PRCDM
PRCDM, ¿¬±¸±³¼ö
RCTC
RCTC, BMRC
¿¬µµº° :
¼±ÅÃÇϱâ
2015-International
2015-Domestic
2014-International
2014-Domestic
2013-International
2013-Domestic
2012-International
2012-Domestic
2011-International
2011-Domestic
2010-International
2010-Domestic
2009-International
2009-Domestic
2008-International
2008-Domestic
2007-International
2007-Domestic
2006-International
2006-Domestic
2005-International
2005-Domestic
2004-International
2004-Domestic
2003-International
2003-Domestic
¸ðµÎº¸±â
·
Lenzini P, Wadelius M, ... Shin J, Kim H, ... Berg RL, Deloukas P, Gage BF.
Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing(PRCDM)
Clin Pharmacol Ther. 87(5):572-8 / 2010.05 [
LINK
]
2010-International
·
Lee SJ, Jang YJ, Cha EY, Kim HS, Lee SS, Shin JG
A haplotype of CYP2C9 associated with warfarin sensitivity in mechanical heart valve replacement patients(BMRC, PRCDM)
Br J Clin Pharmacol. 70(2):213-21. / 2010.08 [
LINK
]
2010-International
·
Limdi NA, Wadelius M, ~ Pirmohamed M, Shin JG, ~ Klein TE, Wagner MJ
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across three racial groups.(BMRC, PRCDM)
Blood 115(18):3827-34 / 2010.05 [
LINK
]
2010-International
·
Kim H, Bae SK, Park SJ, Shim EJ, Kim HS, Shon JH, Liu KH, Shin JG
Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects.(BMRC, PRCDM)
Br J Clin Pharmacol. 70(1):126-31 / 2010.07 [
LINK
]
·
Shin HJ, Lee CH, Park SJ, Shin JG, Song IS
Establishment and characterization of Mardin-Darby canine kidney cells stably expressing human organic anion transporters.(PRCDM, ¿¬±¸±³¼ö)
Arch Pharm Res. 33(5):709-16 / 2010.05 [
LINK
]
·
Lee SJ, Kim WY, Choi JY, Lee SS, Shin JG.
Identification of CYP19A1 single nucleotide polymorphisms and their haplotype distributions in a Korean population(BMRC, PRCDM)
J Hum Genet. 55(3):189-93 / 2010.03 [
LINK
]
·
Shon JH, Yeo CW, Liu KH, Lee SS, Cha IJ, Shin JG
Significantly the Disposition and Antihistamine Effect of Ebastine and Its Metabolites in Healthy Participants(BMRC, PRCDM)
J Clin Pharmacol. 50(2):195-204 [
LINK
]
2010-International
·
Choi H, Gwak J, Cho M, Ryu MJ, Lee JH, Kim SK, Kim YH, Lee GW, Yun MY, Cuong NM, Shin JG, Song GY, Oh S.
Murrayafoline A attenuates the Wnt/beta-catenin pathway by promoting the degradation of intracellular beta-catenin proteins.()
Biochem Biophys Res Commun. 391(1):915-20 [
LINK
]
2010-International
·
Lee SS, Jung HJ, Park JS, Cha IJ, Cho DY, Shin JG
Identification of a null allele of cytochrome P450 3A7: CYP3A7 polymorphism in a Korean population(BMRC)
Mol Biol Rep. 37(1):213-7 [
LINK
]
2010-International
·
Shin HJ, Lee CH, Lee SS, Song IS, Shin JG
Identification of genetic polymorphisms of human OAT1 and OAT2 genes and their relationship to hOAT2 expression in human liver(BMRC, ¼ö¼Ûü)
Clinica Chimica Acta 411(1-2):99-105 [
LINK
]
2010-International
[prev]
11
12
13
14
15
16
17
18
19
20
[Next]
Á¦¸ñ
ÀúÀÚ¸í
Áö¿ø°úÁ¦